Active Cancer Biomarkers Grants

PI Namesort ascending Organization - Company Title Major Program / Research Group FOA
Wolpin, Brian Matthew Dana-Farber Cancer Inst Altered metabolism and machine learning for pancreatic cancer early detection Pancreatic Cancer Detection Consortium PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units
Weissleder, Ralph Massachusetts General Hospital Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) PAR-16-276: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
Weinberg, Aaron Case Western Reserve University Microfluidic intact cell platform: A novel tool for oral cancer detection PAR-19-150: Exploratory/Developmental Bioengineering Research Grants (EBRG)
Wei, Chia-Lin Jackson Laboratory Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer RFA-CA-19-020: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Wei, Lei Roswell Park Cancer Institute Corp Advancing skin cancer prevention by tackling UV-induced clonogenic mutations PA-19-056: Research Project Grant
Wang, Tza-Huei Jeff Johns Hopkins University A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies RFA-CA-21-004: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Wang, Yinsheng University Of California Riverside Quantitative Adductomics Approaches for Assessing the Occurrence and Repair of DNA Adducts PAR-15-308: Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention
Wang, Tza-Huei Johns Hopkins University Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women PA-20-185: NIH Research Project Grant
Wang, Thomas D University Of Michigan At Ann Arbor Early detection of colorectal cancer in the traditional and serrated pathways Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Vizio, Dolores Di Cedars-Sinai Medical Center High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer PAR-16-276: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
Vigneron, Daniel B University Of California, San Francisco Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients Consortium for Imaging and Biomarkers PAR-16-089: Imaging and Biomarkers for Early Cancer Detection
Umbricht, Christopher B Johns Hopkins University Discovery and validation of early molecular breast cancer risk markers in benign breast disease PA-16-160: NIH Research Project Grant
Turesky, Robert J. University Of Minnesota DNA adductomics of the urinary system PAR-15-308: Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention
Thakur, Mathew Laxman Thomas Jefferson University Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Tempst, Paul Sloan-Kettering Inst Can Research Protein and proteolytic activity biomarkers of early stage pancreatic cancer PA-16-160: NIH Research Project Grant

Pages